Overview

Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia

Status:
Withdrawn
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of ceftobiprole versus a comparator in hospitalized patients with bacteremia.
Phase:
Phase 2
Details
Lead Sponsor:
Basilea Pharmaceutica
Treatments:
Ceftobiprole
Ceftobiprole medocaril
Cephalosporins